CAMP4 Therapeutics Corporation (CAMP) |
| 4.45 -0.05 (-1.11%) 07-14 16:00 |
| Open: | 4.52 |
| High: | 4.71 |
| Low: | 4.43 |
| Volume: | 164,447 |
| Market Cap: | 95(M) |
| PE Ratio: | -1.89 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 5.25 |
| Resistance 1: | 4.67 |
| Pivot price: | 4.31 |
| Support 1: | 3.74 |
| Support 2: | 3.11 |
| 52w High: | 7.75 |
| 52w Low: | 1.32 |
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Financials
| EPS | -50290000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 10.1 |
| Return on Equity (ttm) | -38.7 |
Company news
Thu, 02 Jul 2026
Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones? - Yahoo Finance
Sun, 28 Jun 2026
Camp4 Therapeutics Corporation(NasdaqGM:CAMP) added to Russell Small Cap Completeness Index - marketscreener.com
Sun, 28 Jun 2026
Camp4 Therapeutics Corporation(NasdaqGM: CAMP) added to Russell 3000 Index - marketscreener.com
Thu, 25 Jun 2026
CAMP Forecast — Price Target — Prediction for 2027 - TradingView
Fri, 19 Jun 2026
CAMP4 lures 3 new hires with 39,000 stock options - Stock Titan
Fri, 19 Jun 2026
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
